What is Vitalograph?
Founded in 1963, Vitalograph has established itself as a premier provider of accurate and reliable respiratory diagnostic solutions. The company's products are essential tools for healthcare professionals, enabling them to deliver optimal patient care across more than 110 countries. With a strong presence in the US since 1969, Vitalograph plays a critical role in both routine healthcare and clinical drug trial services, underscoring its importance in the medical device and diagnostics sector.
How much funding has Vitalograph raised?
Vitalograph has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Vitalograph?
The recent large-scale, late-stage funding indicates Vitalograph is poised for significant expansion and further innovation in respiratory diagnostics. This strategic investment will likely fuel advancements in product development, enhance global market reach, and potentially support the expansion of its clinical drug trial services. As a company with a long-standing reputation for accuracy and reliability, this capital injection positions Vitalograph to further solidify its leadership in the competitive respiratory health market.
See full Vitalograph company page
